Blocking Trump's Lower Cost Insulin and Epinephrine Mandate

On Day 2 – January 21, 2021, Biden’s Department of Health and Human Services (HHS) announced the new rule would be put on hold, along with several other Trump-era orders pending a 60-day review.

Why?

https://www.modernhealthcare.com/community-health-centers/hhs-freezes-rule-targeting-community-health-centers-drug-discounts

https://thefederalist.com/2021/01/24/biden-freezes-trump-rule-aimed-at-lowering-insulin-epipen-prices/

https://www.foxnews.com/politics/biden-trump-hhs-rule-lower-insulin-prices

https://news.bloomberglaw.com/pharma-and-life-sciences/bidens-hhs-freezes-trump-insulin-epinephrine-rule-until-march

Biden reversed Trump's Executive Order to reduce pricing for insulin and epinephrine.

Democrats want higher insulin prices? pic.twitter.com/w85pkIAchG
— Mary Vought (@MaryVought) January 22, 2021